Valuation: Diaceutics PLC

Market Cap 124M 165M 144M 133M 234M 15.72B 238M 1.59B 619M 7.73B 620M 606M 26.62B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 116M 155M 135M 124M 220M 14.74B 223M 1.49B 580M 7.24B 581M 569M 24.96B EV / Sales 2026 *
2.47x
EV / Sales 2027 * 1.98x
Free-Float
71.23%
Yield 2026 *
-
Yield 2027 * -
1 week+0.69%
1 month-4.58%
3 months-5.50%
6 months+13.62%
Current year+14.06%
1 week 144
Extreme 144
148
1 month 136
Extreme 136
150
Current year 125
Extreme 125
180
1 year 113
Extreme 113
180
3 years 82
Extreme 82
180
5 years 74
Extreme 74
180
10 years 74
Extreme 74
195
Manager TitleAgeSince
Chief Executive Officer 42 2023-12-31
Director of Finance/CFO - 2022-03-17
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 2024-09-30
Director/Board Member 42 -
Director/Board Member 42 2024-09-30
Date Insider Type Main position Quantity % Market Cap.
May. 04Buy

Director

90 0.0001%
May. 04Buy

Chief Financial Officer

90 0.0001%
May. 04Free

Chief Financial Officer

90 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.69%+25.32%+71.76% 165M
-5.92%-10.27%+329.09%+1,038.44% 55.21B
-6.56%-5.69% - - 5.86B
+0.37%-13.00%+37.60%+39.13% 4.18B
0.00%+3.66%+25.74%+106.53% 3.2B
-0.60%+5.34%-26.40%-51.62% 1.24B
-0.66%+0.52%-36.74%+30.12% 1.23B
-0.21%0.00%+28.72%+245.71% 1.23B
-0.33%+9.17%-19.29%-48.73% 1.23B
Average -1.55%-0.20%+45.51%+178.92% 8.17B
Weighted average by Cap. -4.98%-12.02%+271.05%+857.84%

Financials

2026 *2027 *
Net sales 47M 62.77M 54.87M 50.43M 89.15M 5.98B 90.5M 605M 235M 2.94B 236M 231M 10.12B 56.31M 75.2M 65.74M 60.42M 107M 7.16B 108M 725M 282M 3.52B 282M 276M 12.13B
Net income -1.1M -1.47M -1.28M -1.18M -2.09M -140M -2.12M -14.17M -5.51M -68.75M -5.51M -5.4M -237M 1.5M 2M 1.75M 1.61M 2.85M 191M 2.89M 19.32M 7.51M 93.75M 7.52M 7.36M 323M
Net Debt -7.71M -10.3M -9M -8.27M -14.62M -980M -14.85M -99.3M -38.6M -482M -38.65M -37.82M -1.66B -12.14M -16.21M -14.17M -13.02M -23.02M -1.54B -23.37M -156M -60.76M -758M -60.83M -59.52M -2.61B
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Date Price Change Volume
26-07-03 GBX 146.00 0.00% 20,585
26-07-02 GBX 146.00 0.00% 13,247
26-07-01 GBX 146.00 0.00% 31,614
26-06-30 GBX 146.00 +1.04% 37,575
26-06-29 GBX 144.50 -0.34% 13,348
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.460GBP
Average target price
2.130GBP
Spread / Average Target
+45.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXRX Stock